Combination Therapies + Lifestyle Modifications for Traumatic Brain Injury
(CoINTEGRATE Trial)
Trial Summary
What is the purpose of this trial?
This trial tests if combining talking therapy, brain exercises, and lifestyle changes can help people with neurocognitive disorders live better lives by improving their thinking, brain function, and daily habits.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you are on intravenous or oral steroids for MS, you may not be eligible to participate.
What data supports the effectiveness of the treatment Combination Therapies + Lifestyle Modifications for Traumatic Brain Injury?
Research suggests that cognitive rehabilitation and behavioral health interventions, including Cognitive Behavioral Therapy (CBT) and lifestyle modifications, can help manage symptoms in individuals with traumatic brain injury (TBI). These approaches have shown promise in improving emotional distress and promoting healthy lifestyle changes, which are important for recovery.12345
Is the combination of therapies and lifestyle modifications safe for people with traumatic brain injury?
The studies reviewed suggest that cognitive and lifestyle interventions, such as cognitive behavioral therapy and healthy lifestyle programs, are generally safe for people with traumatic brain injury. Participants in these programs reported positive experiences, and no significant safety concerns were noted.12456
How is the treatment of combination therapies and lifestyle modifications for traumatic brain injury different from other treatments?
This treatment is unique because it combines multiple therapies, such as Cognitive Behavioral Therapy (CBT) and Cognitive Rehabilitation Therapy (CRT), with lifestyle changes to address the complex nature of traumatic brain injury (TBI), rather than focusing on a single therapy. This approach aims to target different aspects of TBI simultaneously, potentially leading to better outcomes than using one therapy alone.378910
Research Team
Hala Darwish, PhD
Principal Investigator
University of Michigan
Eligibility Criteria
This trial is for adults over 50 with mild cognitive impairment (MCI) or those aged 21-65 with traumatic brain injury (TBI), multiple sclerosis (MS), or long COVID, experiencing certain levels of cognitive decline. They must be part of the Michigan medicine network and able to consent. Excluded are individuals with severe depression, suicidal thoughts, other major neurological conditions, recent MS relapse, diagnosed sleep disorders, sensory impairments, substance abuse issues, or currently in similar therapies.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive comprehensive multimodal individually tailored Cognitive Behavioral Therapy (CBT), Cognitive Rehabilitation Therapy (CRT), and modifiable lifestyle sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- CBT (Behavioural Intervention)
- CRT (Behavioural Intervention)
- Modifiable lifestyle factors (Behavioural Intervention)
- Usual care Psychoeducation (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
Marschall S. Runge
University of Michigan
Chief Executive Officer since 2015
MD, PhD
Karen McConnell
University of Michigan
Chief Medical Officer since 2020
MD